Press release
Global Uterine Fibroids Treatment Devices Market is projected by DelveInsight to grow at a CAGR of 8.57% by 2032, states DelveInsight
Uterine Fibroids Treatment Devices Market
According to DelveInsight's analysis, the growing prevalence of uterine fibroids particularly among women of reproductive age is significantly increasing the need for advanced treatment devices. Rising awareness of the condition, coupled with improved access to healthcare services, is enabling earlier diagnosis and timely intervention. At the same time, rapid technological progress has resulted in the development of minimally invasive and highly effective treatment solutions that enhance patient outcomes and reduce recovery times. Leading companies in the Uterine Fibroids Treatment Devices market are heavily investing in R&D, introducing next-generation innovations such as advanced ablation platforms and robotic-assisted surgical technologies. Collectively, these drivers are expected to propel strong market growth from 2025 to 2032.
To explore why North America remains at the forefront of global market expansion, request a preview of the Uterine Fibroids Treatment Devices Market Trends - https://www.delveinsight.com/sample-request/uterine-fibroids-treatment-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Uterine Fibroids Treatment Devices Overview
Uterine Fibroids Treatment Devices are utilized to manage symptomatic fibroids by improving clinical outcomes, preserving uterine function, and reducing patient discomfort. These technologies support procedures that range from minimally invasive ablation to robotic-assisted interventions, ensuring enhanced precision and faster recovery. Their use has become increasingly common as patients and clinicians continue to prefer non-invasive and uterus-sparing treatment approaches.
DelveInsight Analysis on Uterine Fibroids Treatment Devices Market:
The global Uterine Fibroids Treatment Devices market is projected to grow at a CAGR of 8.57% between 2025 and 2032, driven by rising disease prevalence, advancements in device technology, and expanding treatment accessibility.
Uterine Fibroids Treatment Devices Market Insights
In 2023, North America accounted for the largest share of the global market. This dominance is attributed to:
• High incidence of uterine fibroids
• Strong preference for minimally invasive procedures
• Robust diagnostic awareness
• Frequent product launches and continuous innovation by top MedTech developers
These factors firmly position North America as a key growth engine for the global Uterine Fibroids Treatment Devices market.
For more insights and key market highlights, access the Uterine Fibroids Treatment Devices Market Report - https://www.delveinsight.com/sample-request/uterine-fibroids-treatment-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Recent Market Developments in Uterine Fibroids Treatment Devices
• January 2025: Hologic, Inc. completed the acquisition of Gynesonics, Inc., adding the Sonata System an incision-less, ultrasound-guided radiofrequency ablation platform-to its portfolio for treating symptomatic fibroids.
• October 2024: Caldera Medical acquired UVision 360, Inc., expanding its expertise in minimally invasive gynecologic care through the LUMINELLE® hysteroscopy and cystoscopy systems.
• May 2024: Meditrina received FDA 510(k) clearance for its next-generation bipolar RF hysteroscopy system, including the new Aveta Glo device, marking a significant advancement in minimally invasive gynecologic surgery.
These innovations are expected to accelerate market growth through the forecast period.
Key Companies in the Uterine Fibroids Treatment Devices Market
Major Uterine Fibroids Treatment Devices manufacturers include Hologic, Inc., Merit Medical Systems, Insightec, Boston Scientific Corporation, Profound Medical, Olympus Corporation, Medtronic, Intuitive Surgical, KARL STORZ, Cook, The Cooper Companies Inc., Terumo Corporation, Stryker, CONMED Corporation, Minerva Surgical, Inc., Smith+Nephew, Momentis Innovative Surgery, Asensus Surgical US, Inc., Koninklijke Philips N.V., Johnson & Johnson Services, Inc., among others.
To explore which MedTech innovators are shaping the future of this market, request insights here - https://www.delveinsight.com/sample-request/uterine-fibroids-treatment-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Uterine Fibroids Treatment Devices Market Landscape Analysis
Hysterectomies remain one of the most frequently performed surgical procedures for managing severe fibroid cases. The rising global volume of hysterectomies-driven by symptoms such as intense pelvic pain, excessive bleeding, or pressure from large fibroids-is contributing to increased adoption of advanced treatment devices. According to NHS England (2024), over 1,000 hysterectomies are performed each week in the UK, highlighting substantial clinical demand. This surge boosts the requirement for electrosurgical tools, laparoscopic systems, and robotic-assisted platforms, reinforcing market growth worldwide.
Scope of the Uterine Fibroids Treatment Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Segmentation by Product Type: Instruments, Consumables
• Segmentation by Procedure Type: Invasive; Minimally Invasive (Laparoscopic RFA, Ultrasound RFA, Robotic-Assisted Surgery, etc.)
• Segmentation by End-User: Hospitals, Ambulatory Surgical Centers, Others
• Geographical Segmentation: North America, Europe, Asia-Pacific, Rest of the World
• Key Company Profiles: Hologic, Insightec, Boston Scientific, Medtronic, Stryker, Olympus, KARL STORZ, and more
• Additional Analysis: Porter's Five Forces, Product Profiles, Case Studies, KOL Insights, Analyst Perspectives
Download free sample report - - https://www.delveinsight.com/sample-request/uterine-fibroids-treatment-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Uterine Fibroids Treatment Devices Market is projected by DelveInsight to grow at a CAGR of 8.57% by 2032, states DelveInsight here
News-ID: 4281986 • Views: …
More Releases from DelveInsight Business Research
Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by …
In 2023, the Limbal Stem Cell Deficiency (LSCD) market was dominated by the United States, generating nearly USD 1.5 billion in revenue, while Spain represented the smallest market with approximately USD 127 million. This regional distribution is expected to remain consistent throughout the forecast timeline. The US accounted for nearly 103,000 diagnosed LSCD cases, whereas Japan recorded around 37,000 cases, with both countries projected to witness notable growth in patient…
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Ther …
The major players operating in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market include Roche, Prometheus Biosciences, Inc., Merck, GlaxoSmithKline, Genentech, Inc., Acceleron, Boehringer Ingelheim, Actelion, Hôpital Claude-Huriez, Changchun GeneScience Pharmaceutical, among others.
DelveInsight's report titled "Systemic Sclerosis-associated Interstitial Lung Disease Market Insights, Epidemiology, and Forecast-2034" delivers a comprehensive analysis of SSc-ILD, covering historical data, projected epidemiology, and evolving market trends across the United States, EU4 (Germany, Spain, Italy, and France),…
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerat …
The Developmental and Epileptic Encephalopathy (DEE) treatment market across the seven major markets (7MM) was valued at nearly USD 2.1 billion in 2023 and is expected to register a healthy compound annual growth rate over the forecast period. The United States emerged as the largest contributor, capturing close to 80% of the overall market revenue.
The DEE treatment landscape is undergoing a significant transformation as the limitations of traditional antiepileptic drugs…
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Co …
DelveInsight's "Polycythemia Vera Pipeline Insight 2025" report delivers an in-depth overview of the Polycythemia Vera pipeline landscape, covering more than 8 companies and 10+ pipeline candidates. The report analyzes both clinical-stage and preclinical assets, offering detailed drug profiles across various stages of development. It also evaluates Polycythemia Vera therapies based on product classification, development stage, route of administration, and molecular category, while additionally spotlighting inactive or discontinued pipeline assets.
Explore the…
More Releases for Uterine
Uterine Fibroids Symptoms
USA Fibroids Center is here to offer detailed information on https://www.usafibroidcenters.com/blog/uterine-fibroids-symptoms/ and help you discuss the best treatments for uterine fibroids at the clinic.
Find out the best Fibroid Treatment for you!
Treatments for uterine fibroids are accessed in women with problems related to them and show symptoms such as heavy menstrual bleeding, pain or pressure in the pelvis, or infertility and sterility.
…
Bharath Hospital Kottayam Offers Minimally Invasive Treatment for Uterine Fibroi …
Bharath Hospital Kottayam is excited introduce the latest advancement in women's healthcare - the Uterine Fibroid Embolization (UFE) treatment. Uterine fibroids are non-cancerous growths that form in the uterus. They are a common condition among women, especially those of reproductive age. These tumors can vary in size, from small growths to large masses that can distort the shape of the uterus. Although many women with uterine fibroids experience no symptoms,…
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Uterine Fibroids Treatment Market : Hysterectomy to Remain Most Preferred Uterin …
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players…
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape.
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers…
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort.
According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to…
